via Pioneering Minds
A drug molecule “invented” by artificial intelligence (AI) will be used in human trials in a world first for machine learning in medicine.
It was created by British start-up Exscientia and Japanese pharmaceutical firm Sumitomo Dainippon Pharma.
The drug will be used to treat patients who have obsessive-compulsive disorder (OCD).
Typically, drug development takes about five years to get to trial, but the AI drug took just 12 months.
Exscienta chief executive Prof Andrew Hopkins described it as a “key milestone in drug discovery”.
He told the BBC: “We have seen AI for diagnosing patients and for analysing patient data and scans, but this is a direct use of AI in the creation of a new medicine.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
AI designed drug
- Global Drug Discovery Software market valued at $2 billion in 2020, is expected to grow at a CAGR of 14% to cross $3.5 billion by 2025
Description: The global drug discovery software market (such as ligand-based design, structure-based design, LIMS, ELN) is driven by the increasing R&D spend ...
- Sygnature Discovery to Deploy Iktos's AI for Drug Design Software Makya™
Iktos, a company specialized in Artificial Intelligence (AI) for new drug design and Sygnature Discovery, a leading integrated drug discovery CRO headquartered in Nottingham, UK, with expertise across ...
- AI In Pharma Global Market Report 2022
The "AI In Pharma Global Market Report 2022, By Technology, Drug Type, Application" report has been added to ResearchAndMarkets.com's offering.
- Can AI transformer models help design drugs and treat incurable diseases?
Special report AI can study chemical molecules in ways scientists can't comprehend, automatically predicting complex protein structures and designing new drugs, despite having no real understanding of ...
- Can transformers help design new AI drugs and treat incurable diseases?
Analysis AI can study chemical molecules in ways scientists can't comprehend, automatically predicting complex protein structures and designing new drugs, despite having no real understanding of ...
Go deeper with Google Headlines on:
AI designed drug
Go deeper with Bing News on:
Machine learning in medicine
- Researchers look to deliver ‘unbiased judgment of AI bias’ in medicine
After an explosion of excitement in the potential for machine learning in medicine, cracks in the foundation are emerging. Now some researchers advocate a framework for assessing bias.
- Machine learning analyzes temperament data to classify infants by gender and age
It's hard to tell the difference between a newborn boy and girl based solely on temperament characteristics such as the baby's propensity to display fear, smile or laugh. But once babies reach around ...
- Machine-Learning Models Outperform Clinicians in Predicting Cancer Growth
May 04, 2022 - Researchers have developed lymph node metastasis (LNM) prediction models based on natural language processing (NLP) and machine-learning (ML ... data related to demographic information, ...
- Unique machine-learning model predicts homelessness among US soldiers before their transition to civilian life
Their study, published in American Journal of Preventive Medicine, used an innovative machine-learning approach to accurately predict which military personnel are at greatest risk and should ...
- Machine-learning-assisted model addresses overprescribing and underprescribing of opioids
Now, a multidisciplinary team of physicians and scientists at Beth Israel Deaconess Medical Center (BIDMC) have designed an intervention—a model that uses machine learning to improve post ...
